Company Intelligence

1580 companies tracked — sector, funding, valuation and headline metrics, sourced and dated.

This week

derived from sourced changes
Most changed companies
Recently funded
Clear

Companies

133 matches
Scribe Therapeutics
Public
Biotech

Clinical-stage biotech developing CRISPR-based gene-editing therapeutics using its proprietary CasX…

$542.77M market cap · Sep 4, 2026
Attovia Therapeutics
Public
Biotech

Attovia Therapeutics is a clinical-stage biotech developing ATTOBODY-based biotherapeutics for immu…

~$588M ($256M private + $332M IPO gross…
Braveheart Bio
Public
Biotech

Braveheart Bio is a clinical-stage biotech developing an oral cardiac myosin inhibitor (BHB-1893) f…

~$1.7B-$2.2B (Sept 2026; sources vary)…
Latigo Biotherapeutics
Public
Biotech

Latigo Biotherapeutics develops non-opioid Nav1.8 pain medicines led by candidate LTG-001; it went…

~$1.39B (Sept 2026) market cap · Sep 20…
ADARx
Biotech

ADARx Pharmaceuticals is a San Diego clinical-stage biotech developing RNA-editing and siRNA therap…

$839.6M valuation · Aug 9, 2023
Chai Discovery
Biotech

Chai Discovery builds generative AI foundation models that predict and design protein and antibody…

$3.8B valuation · Jul 17, 2026
Colossal Biosciences
Biotech

Colossal Biosciences is a genetic engineering company working to de-extinct species like the woolly…

$10.32B valuation · Sep 18, 2025
Iambic
Biotech

San Diego biotech combining AI-driven predictive modeling, physics-based molecular design and autom…

Apnimed
Public
Biotech

Clinical-stage biotech developing Oxnimbi (AD109), the first investigational oral pill for obstruct…

$1.52B market cap · Sep 4, 2026
Iambic Therapeutics
Biotech
Retension Pharmaceuticals
Biotech
Eli Lilly
Public
Biotech
Electra Therapeutics
Biotech
~$401.2M total funding · Sep 21, 2026
City Therapeutics
Biotech
TRex Bio
Biotech
Precision Neuroscience
Biotech

Precision Neuroscience develops a minimally invasive, high-resolution brain-computer interface (the…

~$1B valuation · Sep 24, 2026
AbbVie
Biotech
BlossomHill
Biotech
Celea Therapeutics
Biotech

Clinical-stage biotech developing deupirfenidone, a deuterated pirfenidone-derived drug for idiopat…

Neuralink
Biotech
Enveda Biosciences
Biotech
~$2B valuation · Sep 23, 2026
BlossomHill Therapeutics
Biotech
Parabilis Medicines
Biotech
Serina Therapeutics
Biotech
Basecamp Research
Biotech

Basecamp Research is an AI company developing AI-designed medicines.

BillionToOne
Biotech
Bristol Myers Squibb
Public
Biotech
Dare Bioscience
Public
Biotech
Flare Therapeutics
Biotech

Flare Therapeutics is a clinical-stage biotech developing small-molecule drugs that target transcri…

Kailera Therapeutics
Biotech
Kardigan
Biotech
BigHat Biosciences
Biotech
$223M total funding · Sep 24, 2026
BioStem Technologies
Biotech
Heidi Health
Biotech
$900M valuation · Sep 22, 2026
iSpecimen
Biotech
Jaguar Health
Biotech
Jupiter Neurosciences
Public
Biotech

Clinical-stage biotech developing JOTROL, a proprietary high-bioavailability resveratrol platform t…

MapLight Therapeutics
Public
Biotech
Merck KGaA
Biotech
Ollin Biosciences
Biotech

Clinical-stage biopharmaceutical company developing best-in-disease therapies for vision-threatenin…

Sanofi
Public
Biotech

Sanofi is a global biopharmaceutical company developing and manufacturing medicines and vaccines ac…

TRexBio
Biotech
Vogenx
Biotech
AEON Biopharma
Public
Biotech

Clinical-stage biopharmaceutical company developing ABP-450 (prabotulinumtoxinA), a biosimilar to B…

$12.01M market cap · Sep 4, 2026
Akari Therapeutics
Biotech
Aptevo Therapeutics
Biotech
Astromech
Biotech
$3.8B valuation · Aug 20, 2026
Aureka Biotechnologies
Biotech